Antoni Torres Martí-rekin lankidetzan egindako argitalpenak (19)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376

  2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  2. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

2021

  1. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

    ERJ Open Research, Vol. 7, Núm. 1

  2. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort

    eLife

  3. The value of open-source clinical science in pandemic response: lessons from ISARIC

    The Lancet Infectious Diseases

2020

  1. The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database

    Critical Care, Vol. 24, Núm. 1

2018

  1. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

    Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344

2016

  1. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207

2014

  1. Assessment of the worldwide burden of critical illness: The Intensive Care Over Nations (ICON) audit

    The Lancet Respiratory Medicine, Vol. 2, Núm. 5, pp. 380-386

  2. DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?

    Clinical Infectious Diseases, Vol. 58, Núm. 8, pp. 1072-1083

  3. Decrease in Mortality in severe community-acquired pneumococcal pneumonia: Impact of improving antibiotic strategies (2000-2013)

    Chest, Vol. 146, Núm. 1, pp. 22-31

  4. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 423-430

2013

  1. Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

    Intensive Care Medicine, Vol. 39, Núm. 4, pp. 693-702

2007

  1. Risk factors for candidaemia in critically ill patients: A prospective surveillance study

    Mycoses, Vol. 50, Núm. 4, pp. 302-310

2003

  1. Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit

    Infection Control and Hospital Epidemiology, Vol. 24, Núm. 3, pp. 207-213

2000

  1. Tracheal colonisation within 24 h of intubation in patients with head trauma: Risk factor for developing early-onset ventilator-associated pneumonia

    Intensive Care Medicine, Vol. 26, Núm. 9, pp. 1369-1372